Home
/
Neurogene Inc.
/
Financials
/
Quarterly
Neurogene Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Neurogene Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 13, 2025
Q2
2025
Jun 30, 2025
$0
Aug 11, 2025
Q3
2025
Sep 30, 2024
$0
Nov 13, 2025
Q2
2025
Jun 30, 2024
$925.0K
Aug 11, 2025
Q3
2024
Sep 30, 2023
$0
Nov 18, 2024
Q2
2024
Jun 30, 2023
$0
Aug 9, 2024
Q3
2019
Dec 31, 2018
$25.00M
Nov 13, 2019
Q2
2019
Dec 31, 2018
$25.00M
Aug 1, 2019
Q3
2019
Sep 30, 2018
$25.00M
Nov 13, 2019
Q2
2019
Jun 30, 2018
$25.00M
Aug 1, 2019
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($20.95M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($22.02M)
Aug 11, 2025
Q3
2025
Jun 30, 2025
($22.02M)
Nov 13, 2025
Q2
2025
Mar 31, 2025
($22.65M)
Aug 11, 2025
Q3
2025
Mar 31, 2025
($22.65M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($22.65M)
May 9, 2025
Q3
2025
Sep 30, 2024
($20.22M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($18.49M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($18.49M)
Aug 11, 2025
Q3
2025
Mar 31, 2024
($16.92M)
Nov 13, 2025
Q2
2025
Mar 31, 2024
($16.92M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($16.92M)
May 9, 2025
Q3
2024
Sep 30, 2023
($14.58M)
Nov 18, 2024
Q3
2024
Jun 30, 2023
($11.86M)
Nov 18, 2024
Q2
2024
Jun 30, 2023
($11.86M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($12.26M)
May 10, 2024
Q2
2024
Mar 31, 2023
($12.26M)
Aug 9, 2024
Q3
2024
Mar 31, 2023
($12.26M)
Nov 18, 2024
Q3
2023
Sep 30, 2022
($13.07M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($15.69M)
Aug 10, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($23.80M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($26.08M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($25.92M)
May 9, 2025
Q3
2025
Sep 30, 2024
($22.18M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($20.13M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($18.78M)
May 9, 2025
Q3
2024
Sep 30, 2023
($15.22M)
Nov 18, 2024
Q2
2024
Jun 30, 2023
($12.60M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($13.04M)
May 10, 2024
Q3
2023
Sep 30, 2022
($13.61M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($15.87M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($15.37M)
May 8, 2023
Q3
2022
Sep 30, 2021
($15.45M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($15.12M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($14.95M)
May 9, 2022
Q3
2021
Sep 30, 2020
($2.25M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($9.77M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($9.07M)
May 12, 2021
Q3
2020
Sep 30, 2019
($59.52M)
Nov 9, 2020
Q2
2019
Jun 30, 2019
($428.0K)
Aug 1, 2019